Cargando…
Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility
BACKGROUND: Protein kinase D (PKD) has been implicated in a wide range of cellular processes and pathological conditions including cancer. However, targeting PKD therapeutically and dissecting PKD-mediated cellular responses remains difficult due to lack of a potent and selective inhibitor. Previous...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873968/ https://www.ncbi.nlm.nih.gov/pubmed/20444281 http://dx.doi.org/10.1186/1472-6769-10-5 |